Linglin Yang
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Intralesional Bacillus Calmette-Guérin injections and hypo-fractionated radiation synergistically induce systemic antitumor immune responses.
Journal: International immunopharmacology
Published: August 13, 2022
Prognostic value of PD-L1 and Siglec-15 expression in patients with nasopharyngeal carcinoma.
Journal: Scientific reports
Published: December 17, 2021
FBXL19-AS1 aggravates the progression of hepatocellular cancer by downregulating KLF2.
Journal: Journal of B.U.ON. : official journal of the Balkan Union of Oncology
Published: September 26, 2021
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
Patient-Derived Organoids Can Guide Personalized-Therapies for Patients with Advanced Breast Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: March 23, 2021
HeLa Cell-Derived Paclitaxel-Loaded Microparticles Efficiently Inhibit the Growth of Cervical Carcinoma.
Journal: International journal of nanomedicine
Published: January 21, 2020
Management of Chemotherapy for Stage II Nasopharyngeal Carcinoma in the Intensity-Modulated Radiotherapy Era: A Review.
Journal: Cancer management and research
Published: November 22, 2019
Chronic chemotherapy with paclitaxel nanoparticles induced apoptosis in lung cancer in vitro and in vivo.
Journal: International journal of nanomedicine
Published: March 14, 2019
Naproxen Nanoparticle-Loaded Thermosensitive Chitosan Hydrogel for Prevention of Postoperative Adhesions.
Journal: ACS biomaterials science & engineering
Published: March 11, 2019
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer.
Journal: International journal of nanomedicine
Published: December 28, 2018
Prognostic value of TIGAR and LC3B protein expression in nasopharyngeal carcinoma.
Journal: Cancer management and research
Published: December 07, 2018
Glycyrrhetinic Acid-Modified Norcantharidin Nanoparticles for Active Targeted Therapy of Hepatocellular Carcinoma.
Journal: Journal of biomedical nanotechnology
Published: February 22, 2018
Last Updated: 09/26/2026